BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34942511)

  • 21. [Glial and glioneuronal tumors in adults and children: main genetic alterations and towards a histomolecular classification].
    Figarella-Branger D; Chappe C; Padovani L; Mercurio S; Colin C; Forest F; Bouvier C
    Bull Cancer; 2013; 100(7-8):715-26. PubMed ID: 23831947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BRAF V600E mutation is associated with mTOR signaling activation in glioneuronal tumors.
    Prabowo AS; Iyer AM; Veersema TJ; Anink JJ; Schouten-van Meeteren AY; Spliet WG; van Rijen PC; Ferrier CH; Capper D; Thom M; Aronica E
    Brain Pathol; 2014 Jan; 24(1):52-66. PubMed ID: 23941441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Desmoplastic non-infantile astrocytoma/ganglioglioma: rare low-grade tumor with frequent BRAF V600E mutation.
    Chatterjee D; Garg C; Singla N; Radotra BD
    Hum Pathol; 2018 Oct; 80():186-191. PubMed ID: 29902580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiplex ligation-dependent probe amplification analysis is useful for detecting a copy number gain of the FGFR1 tyrosine kinase domain in dysembryoplastic neuroepithelial tumors.
    Matsumura N; Nobusawa S; Ito J; Kakita A; Suzuki H; Fujii Y; Fukuda M; Iwasaki M; Nakasato N; Tominaga T; Natsume A; Mikami Y; Shinojima N; Yamazaki T; Nakazato Y; Hirato J; Yokoo H
    J Neurooncol; 2019 May; 143(1):27-33. PubMed ID: 30825062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Posterior fossa and spinal gangliogliomas form two distinct clinicopathologic and molecular subgroups.
    Gupta K; Orisme W; Harreld JH; Qaddoumi I; Dalton JD; Punchihewa C; Collins-Underwood R; Robertson T; Tatevossian RG; Ellison DW
    Acta Neuropathol Commun; 2014 Feb; 2():18. PubMed ID: 24529209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome-wide DNA copy number analysis of desmoplastic infantile astrocytomas and desmoplastic infantile gangliogliomas.
    Gessi M; Zur Mühlen A; Hammes J; Waha A; Denkhaus D; Pietsch T
    J Neuropathol Exp Neurol; 2013 Sep; 72(9):807-15. PubMed ID: 23965740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comprehensive analysis of infantile central nervous system tumors to improve distinctive criteria for infant-type hemispheric glioma versus desmoplastic infantile ganglioglioma/astrocytoma.
    Tauziède-Espariat A; Beccaria K; Dangouloff-Ros V; Sievers P; Meurgey A; Pissaloux D; Appay R; Saffroy R; Grill J; Mariet C; Bourdeaut F; Hasty L; Métais A; Chrétien F; Blauwblomme T; Puget S; Boddaert N; Varlet P;
    Brain Pathol; 2023 Sep; 33(5):e13182. PubMed ID: 37349135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular Diagnostic and Prognostic Subtyping of Gliomas in Tunisian Population.
    Trabelsi S; Chabchoub I; Ksira I; Karmeni N; Mama N; Kanoun S; Burford A; Jury A; Mackay A; Popov S; Bouaouina N; Ben Ahmed S; Mokni M; Tlili K; Krifa H; Yacoubi MT; Jones C; Saad A; H'mida Ben Brahim D
    Mol Neurobiol; 2017 May; 54(4):2381-2394. PubMed ID: 26957305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recurrent copy number alterations in low-grade and anaplastic pleomorphic xanthoastrocytoma with and without BRAF V600E mutation.
    Vaubel RA; Caron AA; Yamada S; Decker PA; Eckel Passow JE; Rodriguez FJ; Nageswara Rao AA; Lachance D; Parney I; Jenkins R; Giannini C
    Brain Pathol; 2018 Mar; 28(2):172-182. PubMed ID: 28181325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical characteristics and late effects in CNS tumours of childhood: Do not forget long term follow-up of the low grade tumours.
    Ehrstedt C; Kristiansen I; Ahlsten G; Casar-Borota O; Dahl M; Libard S; Strömberg B
    Eur J Paediatr Neurol; 2016 Jul; 20(4):580-7. PubMed ID: 27157245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BRAF V600E mutations are frequent in dysembryoplastic neuroepithelial tumors and subependymal giant cell astrocytomas.
    Lee D; Cho YH; Kang SY; Yoon N; Sung CO; Suh YL
    J Surg Oncol; 2015 Mar; 111(3):359-64. PubMed ID: 25346165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glioneuronal tumours in neurofibromatosis type 1: MRI-pathological study.
    Fedi M; Anne Mitchell L; Kalnins RM; Gutmann DH; Perry A; Newton M; Brodtmann A; Berkovic SF
    J Clin Neurosci; 2004 Sep; 11(7):745-7. PubMed ID: 15337138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intramedullary gangliogliomas: histopathologic and molecular features of 25 cases.
    Gessi M; Dörner E; Dreschmann V; Antonelli M; Waha A; Giangaspero F; Gnekow A; Pietsch T
    Hum Pathol; 2016 Mar; 49():107-13. PubMed ID: 26826417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical relevance of BRAF status in glial and glioneuronal tumors: A systematic review.
    Sugiura Y; Nagaishi M
    J Clin Neurosci; 2019 Aug; 66():196-201. PubMed ID: 31147232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-Pass Whole-Genome Sequencing as a Method of Determining Copy Number Variations in Uveal Melanoma Tissue Samples.
    Beasley AB; Bentel J; Allcock RJN; Vermeulen T; Calapre L; Isaacs T; Ziman MR; Chen FK; Gray ES
    J Mol Diagn; 2020 Mar; 22(3):429-434. PubMed ID: 31978561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diffuse form of dysembryoplastic neuroepithelial tumour: the histological and immunohistochemical features of a distinct entity showing transition to dysembryoplastic neuroepithelial tumour and ganglioglioma.
    Bodi I; Selway R; Bannister P; Doey L; Mullatti N; Elwes R; Honavar M
    Neuropathol Appl Neurobiol; 2012 Aug; 38(5):411-25. PubMed ID: 21988102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted fusion analysis can aid in the classification and treatment of pediatric glioma, ependymoma, and glioneuronal tumors.
    Lake JA; Donson AM; Prince E; Davies KD; Nellan A; Green AL; Mulcahy Levy J; Dorris K; Vibhakar R; Hankinson TC; Foreman NK; Ewalt MD; Kleinschmidt-DeMasters BK; Hoffman LM; Gilani A
    Pediatr Blood Cancer; 2020 Jan; 67(1):e28028. PubMed ID: 31595628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comprehensive analysis identifies BRAF hotspot mutations associated with gliomas with peculiar epithelial morphology.
    Hatae R; Hata N; Suzuki SO; Yoshimoto K; Kuga D; Murata H; Akagi Y; Sangatsuda Y; Iwaki T; Mizoguchi M; Iihara K
    Neuropathology; 2017 Jun; 37(3):191-199. PubMed ID: 27792249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BRAF V600E mutation in epilepsy-associated glioneuronal tumors: Prevalence and correlation with clinical features in a Chinese population.
    Zhang YX; Shen CH; Guo Y; Zheng Y; Zhu JM; Ding Y; Tang YL; Wang S; Ding MP
    Seizure; 2017 Feb; 45():102-106. PubMed ID: 27984807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of IDH1-R132 mutation, BRAF V600 mutation and KIAA1549-BRAF fusion transcript status in central nervous system tumors supports pediatric tumor classification.
    Gierke M; Sperveslage J; Schwab D; Beschorner R; Ebinger M; Schuhmann MU; Schittenhelm J
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):89-100. PubMed ID: 26115961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.